Today, Paxman publishes the March issue of its newsletter aimed at shareholders, investors and other interested parties.
This issue highlights that Paxman’s CEO Richard Paxman conducted several investor meetings in the United States to follow up on increasing investor interest for the company since the engagement of US based Arrowhead Business and Investment Decisions towards the end of 2022. Visit Arrowhead’s dedicated Paxman Page to learn more about their analysis of the company, and the latest Equity Research Report can be found here.
The newsletter also includes information on that CEO Richard Paxman participated at an export event in Leeds held by the Department for Business and Trade to share knowledge and experience of Paxman’s export journey to the United States, that the prominent US breast cancer physician Alberto Montero visited the Paxman Scalp Cooling Research Centre, successful certifications of distributors from Saudi Arabia, Romania and the Czech Republic, as well as on a number of orders to the United States, the UK and several international markets.
To read the full newsletter, follow this link:
This is the final issue of Paxman’s monthly investor newsletter. Going forward, stakeholders are recommended to follow the news flow directly on Paxman’s website and the company’s social media channels.
